Market MapFertility
PCOS Ecosystem
Therapeutics, virtual care, diagnostics, and supplements competing across the PCOS stack — plotted on clinical depth vs. consumer reach.
Overview
The PCOS economy is bifurcating between deep-clinical therapeutics (Spruce, May Health) and consumer-first diagnostics and supplements. Allara is consolidating insurance-covered virtual care.
PCOS is one of the most under-served conditions in women's health. The map shows where each cohort sits on regulatory depth and consumer reach.
Top-left is biotech with clinical depth and limited DTC; top-right is insurance-covered virtual care; bottom is at-home diagnostics and supplements.
Competitive positioning
2×2 matrix
Each tile links to a company profile when one exists. Axes reflect clinical depth and consumer reach.
↑ Clinical depth / Regulatory maturity
High ← Clinical depth → Low
Consumer reach / DTC →